113 related articles for article (PubMed ID: 3669015)
1. Modulation of the antitumor activity by methyl substitutions in the series of 7H-pyridocarbazole monomers and dimers.
Léon P; Garbay-Jaureguiberry C; Barsi MC; Le Pecq JB; Roques BP
J Med Chem; 1987 Nov; 30(11):2074-80. PubMed ID: 3669015
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor series.
Garbay-Jaureguiberry C; Barsi MC; Jacquemin-Sablon A; Le Pecq JB; Roques BP
J Med Chem; 1992 Jan; 35(1):72-81. PubMed ID: 1732535
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
[TBL] [Abstract][Full Text] [Related]
4. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
[TBL] [Abstract][Full Text] [Related]
5. DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles.
Pelaprat D; Oberlin R; Le Guen I; Roques BP; Le Pecq JB
J Med Chem; 1980 Dec; 23(12):1330-5. PubMed ID: 7452685
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrical bisintercalators as potential antitumor agents.
Léon P; Garbay-Jaureguiberry C; Lambert B; Le Pecq JB; Roques BP
J Med Chem; 1988 May; 31(5):1021-6. PubMed ID: 3283364
[TBL] [Abstract][Full Text] [Related]
7. DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series.
Garbay-Jaureguiberry C; Laugâa P; Delepierre M; Laalami S; Muzard G; Le Pecq JB; Roques BP
Anticancer Drug Des; 1987 Apr; 1(4):323-35. PubMed ID: 3450302
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
[TBL] [Abstract][Full Text] [Related]
9. 1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.
Delepierre M; Maroun R; Garbay-Jaureguiberry C; Igolen J; Roques BP
J Mol Biol; 1989 Nov; 210(1):211-28. PubMed ID: 2585517
[TBL] [Abstract][Full Text] [Related]
10. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.
Esnault C; Roques BP; Jacquemin-Sablon A; Le Pecq JB
Cancer Res; 1984 Oct; 44(10):4355-60. PubMed ID: 6467197
[TBL] [Abstract][Full Text] [Related]
11. Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain.
Garbay-Jaureguiberry C; Esnault C; Delepierre M; Laugaa P; Laalami S; Le Pecq JB; Roques BP
Drugs Exp Clin Res; 1987; 13(6):353-7. PubMed ID: 3652924
[TBL] [Abstract][Full Text] [Related]
12. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
[TBL] [Abstract][Full Text] [Related]
13. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
14. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
[TBL] [Abstract][Full Text] [Related]
16. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
[TBL] [Abstract][Full Text] [Related]
17. A DNA-intercalating compound derived from 7H-pyridocarbazole: the structure of 10-methoxy-2-methyl-7H-pyrido[4,3-c]carbazolium iodide.
Courseille C; Pelaprat D; Tsai CC
Acta Crystallogr C; 1988 Dec; 44 ( Pt 12)():2154-6. PubMed ID: 3270555
[TBL] [Abstract][Full Text] [Related]
18. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
[TBL] [Abstract][Full Text] [Related]
19. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.
Rivalle C; Wendling F; Tambourin P; Lhoste JM; Bisagni E; Chermann JC
J Med Chem; 1983 Feb; 26(2):181-5. PubMed ID: 6827534
[TBL] [Abstract][Full Text] [Related]
20. Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent.
Esnault C; Brown SC; Segal-Bendirdjian E; Coulaud D; Mishal Z; Roques BP; Le Pecq JB
Biochem Pharmacol; 1990 Jan; 39(1):109-22. PubMed ID: 2297352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
